Risk assessment validation in patients with pulmonary arterial hypertension: Data from a Southern Brazil registry (RESPHIRAR study)

Pulmonary arterial hypertension (PAH) is a severe and progressive disease characterized by increased pulmonary vascular resistance, ultimately leading to right heart failure and death. Registries are a valuable tool in the research of rare conditions such as PAH. Moreover, the risk assessment strate...

Descripción completa

Detalles Bibliográficos
Autores principales: Spilimbergo, Fernanda Brum, Pirath Rodrigues, Roger, Credidio Dias‐Pinto, Marcelo, Blanco, Daniela Cavalet, Barbieri, Gláucia Maria, Andrade‐Lima, Marina, Leal Fagundes, Ariovaldo, Gazzana, Marcelo Basso, Roncato, Gabriela, Mello, Marcelo Martins, Watte, Guilherme, Assmann, Taís Silveira, Caurio, Cássia Ferreira Braz, Souza, Rogerio, Meyer, Gisela Martina Bohns
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031811/
https://www.ncbi.nlm.nih.gov/pubmed/36968814
http://dx.doi.org/10.1002/pul2.12193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031811/
https://www.ncbi.nlm.nih.gov/pubmed/36968814
http://dx.doi.org/10.1002/pul2.12193

Ejemplares similares